{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:42:18Z","timestamp":1791322938278,"version":"4.3.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute for Science and Technology of Vaccines (CNPq)"},{"name":"The Network Research in Bio-molecules (FAPEMIG)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.mib.2012.05.002","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T07:18:55Z","timestamp":1339571935000},"page":"476-485","source":"Crossref","is-referenced-by-count":78,"title":["Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives"],"prefix":"10.1016","volume":"15","author":[{"given":"Ana Paula","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Luiz Lins","family":"Machado-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Junior","given":"Gabriel","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Tostes","family":"Gazzinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2012.05.002_bib0005_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QCO.0b013e32830d0ee8","article-title":"Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis","volume":"21","author":"Schriefer","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.mib.2012.05.002_bib0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4269\/ajtmh.1989.41.687","article-title":"A review of the geographic distribution and epidemiology of leishmaniasis in the New World","volume":"41","author":"Grimaldi","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mib.2012.05.002_bib0015","first-page":"289","article-title":"Visceral leishmaniasis in the New World & Africa","volume":"123","author":"Berman","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.mib.2012.05.002_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004300100080","article-title":"Recent advances in the taxonomy of the New World leishmanial parasites","volume":"190","author":"Cupolillo","year":"2001","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0031182003004578","article-title":"Leishmania donovani complex: genotyping with the ribosomal internal transcribed spacer and the mini-exon","volume":"128","author":"Mauricio","year":"2004","journal-title":"Parasitology"},{"key":"10.1016\/j.mib.2012.05.002_bib0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/382077","article-title":"Combating tropical infectious diseases: report of the disease control priorities in developing countries project","volume":"38","author":"Hotez","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2012.05.002_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.mib.2012.05.002_bib0040","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy: challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mib.2012.05.002_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0014-4894(89)90176-8","article-title":"Metacyclogenesis in Leishmania promastigotes","volume":"69","author":"Sacks","year":"1989","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.mib.2012.05.002_bib0050_1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2012.05.002_bib0055","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1462-5822.2009.01348.x","article-title":"The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis","volume":"11","author":"Peters","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.mib.2012.05.002_bib0060_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pt.2010.04.005","article-title":"Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis","volume":"26","author":"Reis","year":"2010","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mib.2012.05.002_bib0065","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/588387","article-title":"Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis","volume":"197","author":"Ganguly","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.05.002_bib0070","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","article-title":"IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India","volume":"179","author":"Saha","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.vetimm.2008.11.020","article-title":"Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi","volume":"128","author":"Alves","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.mib.2012.05.002_bib0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1086\/505228","article-title":"Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar","volume":"194","author":"Ghosh","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.05.002_bib0095","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.2174\/138161206778743556","article-title":"Toll-like receptor-positive cells and recognition of pathogens: how human myeloid dendritic cells respond to in vitro infection with Leishmania infantum","volume":"12","author":"Pepe","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mib.2012.05.002_bib0100","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/IAI.00079-11","article-title":"Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity","volume":"79","author":"Prajeeth","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0105","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.189.4.741","article-title":"Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani","volume":"189","author":"Murray","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2012.05.002_bib0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nyl\u00e9n","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2012.05.002_bib0115","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/eji.200939988","article-title":"IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo","volume":"40","author":"Haeberlein","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0120","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4049\/jimmunol.140.11.3971","article-title":"Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis","volume":"141","author":"Stern","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0125","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1084\/jem.167.6.1927","article-title":"The dynamics of granuloma formation in experimental visceral leishmaniasis","volume":"167","author":"Mc Elrath","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2012.05.002_bib0130","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/IAI.67.11.5559-5566.1999","article-title":"Control of Leishmania infantum infection is associated with CD8+ and IFN-gamma- and interleukin-5-producing CD4+ antigen-specific T cells","volume":"67","author":"Mary","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","article-title":"Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses","volume":"9","author":"Stager","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2012.05.002_bib0140","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1128\/IAI.00944-07","article-title":"Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10), but not IL-4 or IL-13","volume":"75","author":"Basu","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/IAI.74.1.773-776.2006","article-title":"Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen","volume":"74","author":"Polley","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0150_1","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1016\/j.vaccine.2008.05.091","article-title":"Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells","volume":"26","author":"Resende","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","article-title":"Systemic and compartmentalized immune response in canine visceral leishmaniasis","volume":"128","author":"Reis","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.mib.2012.05.002_bib0160","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.4049\/jimmunol.164.7.3681","article-title":"B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology","volume":"164","author":"Smelt","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/IAI.00316-07","article-title":"Fc gamma-RIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions","volume":"76","author":"Thomas","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0170","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2012.05.002_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2008.06.012","article-title":"Post-transcriptional regulation of IL-10 gene expression allows natural killer cells to express immunoregulatory function","volume":"29","author":"Maroof","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.mib.2012.05.002_bib0180","doi-asserted-by":"crossref","first-page":"90520","DOI":"10.1155\/2007\/90520","article-title":"DNA vaccines against protozoan parasites: advances and challenges","volume":"2007","author":"Dumonteil","year":"2007","journal-title":"J Biomed Biotechnol"},{"issue":"Suppl.","key":"10.1016\/j.mib.2012.05.002_bib0185","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.mib.2012.05.002_bib0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-4017(01)00486-1","article-title":"An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine","volume":"100","author":"Gradoni","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.mib.2012.05.002_bib0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.mib.2012.05.002_bib0200","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0205","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0210_1","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the Leishmaniases: proposals for a research agenda. The Working Group on research priorities for development of leishmaniasis vaccines","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.mib.2012.05.002_bib0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL-12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14760584.2.2.239","article-title":"Development of a leishmaniasis vaccine: the importance of MPL","volume":"2","author":"Reed","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.mib.2012.05.002_bib0225","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1128\/IAI.61.8.3351-3359.1993","article-title":"Recombinant vaccinia viruses expressing GP46\/M-2 protect against Leishmania infection","volume":"61","author":"McMahon-Pratt","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.162.2.753","article-title":"A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB\/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice","volume":"162","author":"Gabaglia","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multi-functional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2012.05.002_bib0240","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2012.05.002_bib0245","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.160197797","article-title":"The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory\/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge","volume":"97","author":"Stobie","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2012.05.002_bib0250","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0255","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0260","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"Dondji","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0265","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response","volume":"26","author":"Ramos","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0275","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.vaccine.2008.11.094","article-title":"A prime\/boost DNA\/modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis","volume":"27","author":"Carson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1096\/fj.11-184895","article-title":"Leishmania major parasite stage-dependent host cell invasion and immune evasion","volume":"26","author":"Wenzel","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.mib.2012.05.002_bib0285","doi-asserted-by":"crossref","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of Leishmania abrogates vaccine-induced protective immunity","volume":"5","author":"Peters","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2012.05.002_bib0290","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijpara.2011.01.003","article-title":"The protective effect against Leishmania infection conferred by sand fly bites is limited to short-term exposure","volume":"41","author":"Rohou\u0161ov\u00e1","year":"2011","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.mib.2012.05.002_bib0295","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","article-title":"Development of a safe live Leishmania vaccine line by gene replacement","volume":"92","author":"Titus","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2012.05.002_bib0300","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00005-008-0010-9","article-title":"Live attenuated Leishmania vaccines: a potential strategic alternative","volume":"56","author":"Silvestre","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.mib.2012.05.002_bib0305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/eji.200838389","article-title":"Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis","volume":"39","author":"Kumari","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0310","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/MCB.14.5.2975","article-title":"Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene","volume":"14","author":"Charest","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.mib.2012.05.002_bib0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-6851(96)02612-6","article-title":"Identification and over-expression of the A2 amastigote-specific protein in Leishmania donovani","volume":"78","author":"Zhang","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.mib.2012.05.002_bib0320","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1128\/CDLI.4.5.530-535.1997","article-title":"Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis","volume":"4","author":"Ghedin","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0325_1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2958.2010.07229.x","article-title":"Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein","volume":"77","author":"McCall","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mib.2012.05.002_bib0330","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1073\/pnas.94.16.8807","article-title":"Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2012.05.002_bib0335","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2958.2001.02286.x","article-title":"Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection","volume":"39","author":"Zhang","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mib.2012.05.002_bib0340","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00436-011-2325-4","article-title":"Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae","volume":"109","author":"Mizbani","year":"2011","journal-title":"Parasitol Res"},{"key":"10.1016\/j.mib.2012.05.002_bib0345","doi-asserted-by":"crossref","first-page":"35508","DOI":"10.1074\/jbc.M305030200","article-title":"Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.002_bib0350","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0732-8893(02)00410-8","article-title":"Diagnosis of American Visceral Leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen","volume":"43","author":"Carvalho","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mib.2012.05.002_bib0355","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/CVI.00420-06","article-title":"Comparative evaluation of enzime-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs","volume":"14","author":"Porrozzi","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.mib.2012.05.002_bib0360","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1128\/IAI.02032-05","article-title":"Leishmania chagasi T-cell antigens identified through a double library screen","volume":"74","author":"Martins","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infection","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0370","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.002_bib0375","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/S0264-410X(01)00023-8","article-title":"Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response","volume":"19","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0380","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","article-title":"Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infection","volume":"9","author":"Zanin","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.mib.2012.05.002_bib0385","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1099\/jmm.0.029959-0","article-title":"Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB\/c mice","volume":"60","author":"Yam","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mib.2012.05.002_bib0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vaccine.2009.09.114","article-title":"Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis","volume":"28","author":"Mizbani","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0395_1","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.05.002_bib0400","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/pr101286y","article-title":"Analysis of Leishmania chagasi by 2-D difference gel eletrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine","volume":"10","author":"Costa","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.mib.2012.05.002_bib0405_1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like stages of Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2011","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527412000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527412000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T09:46:00Z","timestamp":1687513560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527412000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1369527412000562"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2012.05.002","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}